

Author: Christensen Robin Tarp Simon Furst Daniel E Kristensen Lars E Bliddal Henning
Publisher: Future Medicine
ISSN: 1758-4272
Source: International Journal of Clinical Rheumatology, Vol.8, Iss.6, 2013-12, pp. : 647-655
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Our objective was to assess the efficacy of infliximab, adalimumab and abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate. The purpose of this type of analysis is to combine evidence from direct and indirect sources into one overall objective. The meta-data set included results from the ATTEST and AMPLE studies. Major outcomes concerned the benefits and harm after 1 year on therapy; coprimary outcomes patients achieving a 50% response on the ACR improvement criteria, extracted from the papers, and the number of withdrawals related to adverse events, respectively. Statistical analyses were based on mixed-effects logistic regression, using an arm-based, random-effects model respecting randomization within each study. Following indirect comparisons across all three groups, we conclude that infliximab, at the recommended dose, is less efficacious than abatacept and potentially also adalimumab, and that adalimumab and abatacept are approximately equivalent both in terms of benefit and short-term harm assessment (up to 1 year).
Related content


Clinical efficacy of abatacept in Japanese rheumatoid arthritis patients
By Takahashi Nobunori Kojima Toshihisa Terabe Kenya Kaneko Atsushi Kida Daihei Hirano Yuji Fujibayashi Takayoshi Yabe Yuichiro Takagi Hideki Oguchi Takeshi Miyake Hiroyuki Kato Takefumi Fukaya Naoki Ishikawa Hisato Hayashi Masatoshi Tsuboi Seiji Kato Daizo Funahashi Koji Matsubara Hiroyuki Hattori Yosuke Hanabayashi Masahiro Hirabara Shinya Yoshioka Yutaka Ishiguro Naoki
Modern Rheumatology, Vol. 23, Iss. 5, 2013-09 ,pp. :


By Bijl Arie Breedveld Ferdinand Antoni Christian Kalden Joachim Kary Sonja Burmester Gerd Beckmann Christina Unnebrink Kristina Kupper Hartmut
Clinical Rheumatology, Vol. 27, Iss. 8, 2008-08 ,pp. :


By Kristensen L. E. Christensen R. Bliddal H. Geborek P. Danneskiold-Samsøe B. Saxne T.
Scandinavian Journal of Rheumatology, Vol. 36, Iss. 6, 2007-01 ,pp. :

